A Comparison of Invokana and Jardiance for the Treatment of Type 2 Diabetes
Invokana (canagliflozin) and Jardiance (empagliflozin) are two medications that belong to a class of drugs called sodium-glucose cotransporter 2 (SGLT2) inhibitors. Both medications are used to treat type 2 diabetes by helping the body remove excess glucose (sugar) from the blood through the urine. Both Invokana and Jardiance are effective at reducing blood sugar levels in people with type 2 diabetes, but they work in slightly different ways. Invokana blocks the SGLT2 protein in the kidney, which helps the body remove excess glucose from the blood and into the urine. Jardiance works in a similar way, but it also increases the amount of insulin produced by the pancreas and reduces the amount of glucose produced by the liver. It is important to note that no one medication is "better" than the other for all individuals. The best medication for a person with type 2 diabetes will depend on various factors, including their specific needs and medical history. It is important to work